Shape Therapeutics Appoints David J. Huss, Ph.D., as Chief Scientific Officer and Lisa Taylor Ash,…
SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief…